Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | PHN-010 |
Synonyms | |
Therapy Description |
Limited information is currently available on PHN-010, a putative antibody-drug conjugate (ADC) targeting an unknown single pass transmembrane protein overexpressed in tumor cells (Jun 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PHN-010 | PHN010|PHN 010 | Limited information is currently available on PHN-010, a putative antibody-drug conjugate (ADC) targeting an unknown single pass transmembrane protein overexpressed in tumor cells (Jun 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06457997 | Phase I | PHN-010 | A Study of PHN-010 in Patients With Advanced Solid Tumors | Recruiting | USA | 0 |